Filing Details

Accession Number:
0001708138-20-000052
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-08 16:04:13
Reporting Period:
2020-05-06
Accepted Time:
2020-05-08 16:04:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1411984 P Daniel Plew Van 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp & General Mgr Industrial O No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-06 33,079 $52.03 61,330 No 4 M Direct
Common Stock Disposition 2020-05-06 17,779 $555.77 43,551 No 4 F Direct
Common Stock Acquisiton 2020-05-06 52,500 $52.03 96,051 No 4 M Direct
Common Stock Disposition 2020-05-06 28,217 $555.77 67,834 No 4 F Direct
Common Stock Disposition 2020-05-07 100 $556.92 67,734 No 4 S Direct
Common Stock Disposition 2020-05-07 600 $557.59 67,134 No 4 S Direct
Common Stock Disposition 2020-05-07 2,118 $558.43 65,016 No 4 S Direct
Common Stock Disposition 2020-05-07 500 $559.20 64,516 No 4 S Direct
Common Stock Disposition 2020-05-07 3,231 $560.53 61,285 No 4 S Direct
Common Stock Disposition 2020-05-07 4,988 $561.55 56,297 No 4 S Direct
Common Stock Disposition 2020-05-07 2,077 $562.45 54,220 No 4 S Direct
Common Stock Disposition 2020-05-07 2,195 $563.58 52,025 No 4 S Direct
Common Stock Disposition 2020-05-07 3,000 $564.54 49,025 No 4 S Direct
Common Stock Disposition 2020-05-07 5,984 $565.49 43,041 No 4 S Direct
Common Stock Disposition 2020-05-07 7,297 $566.47 35,744 No 4 S Direct
Common Stock Disposition 2020-05-07 3,753 $567.35 31,991 No 4 S Direct
Common Stock Disposition 2020-05-07 3,040 $568.57 28,951 No 4 S Direct
Common Stock Disposition 2020-05-07 700 $569.42 28,251 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-05-06 33,079 $0.00 33,079 $52.03
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-05-06 52,500 $0.00 52,500 $52.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
52,500 2021-12-16 No 4 M Direct
0 2021-12-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,561 Indirect By 401(k) Plan
Footnotes
  1. Represents volume-weighted average price of sales of 600 shares of Company stock on May 7, 2020 at prices ranging from $557.13 to $557.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  2. Represents volume-weighted average price of sales of 2,118 shares of Company stock on May 7, 2020 at prices ranging from $558.02 to $558.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  3. Represents volume-weighted average price of sales of 500 shares of Company stock on May 7, 2020 at prices ranging from $559.05 to $559.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  4. Represents volume-weighted average price of sales of 3,231 shares of Company stock on May 7, 2020 at prices ranging from $560.00 to $560.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  5. Represents volume-weighted average price of sales of 4,988 shares of Company stock on May 7, 2020 at prices ranging from $561.00 to $561.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  6. Represents volume-weighted average price of sales of 2,077 shares of Company stock on May 7, 2020 at prices ranging from $562.03 to $562.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  7. Represents volume-weighted average price of sales of 2,195 shares of Company stock on May 7, 2020 at prices ranging from $563.00 to $563.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  8. Represents volume-weighted average price of sales of 3,000 shares of Company stock on May 7, 2020 at prices ranging from $564.04 to $564.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  9. Represents volume-weighted average price of sales of 5,984 shares of Company stock on May 7, 2020 at prices ranging from $565.03 to $565.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  10. Represents volume-weighted average price of sales of 7,297 shares of Company stock on May 7, 2020 at prices ranging from $566.00 to $566.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  11. Represents volume-weighted average price of sales of 3,753 shares of Company stock on May 7, 2020 at prices ranging from $567.00 to $567.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  12. Represents volume-weighted average price of sales of 3,040 shares of Company stock on May 7, 2020 at prices ranging from $568.10 to $568.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  13. Represents volume-weighted average price of sales of 700 shares of Company stock on May 7, 2020 at prices ranging from $569.02 to $569.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
  14. With respect to 33,079 underlying shares (of which 0 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant. With respect to 52,500 underlying shares (of which 0 remain outstanding), the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014.